Johnson & Johnson (JNJ) Total Liabilities (2009 - 2026)

Johnson & Johnson (JNJ) posted Total Liabilities of $119.7 billion for Q1 2026, up 1.74% sequentially from $117.7 billion in Q4 2025, and up 3.59% YoY from $115.6 billion in Q1 2025.

Johnson & Johnson (JNJ) Total Liabilities (2009 - 2026) Analysis & Trends

Johnson & Johnson (JNJ) has 18 years of Total Liabilities data on file, last reported at $119.7 billion in Q1 2026.

  • Quarterly Total Liabilities rose 3.59% year-over-year to $119.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $119.7 billion (up 3.59% YoY) and the FY2025 annual result came in at $117.7 billion, up 8.33% from the prior year.
  • Total Liabilities grew to $119.7 billion in Q1 2026 per JNJ's latest filing, from $117.7 billion in the prior quarter.
  • The five-year high for Total Liabilities was $125.1 billion in Q2 2023, with the low at $94.8 billion in Q4 2023.
  • Average Total Liabilities over 5 years is $109.3 billion, with a median of $109.1 billion recorded in 2024.
  • Year-over-year, Total Liabilities climbed 20.7% in 2023 and fell 18.51% in 2024.
  • Johnson & Johnson's Total Liabilities stood at $100.5 billion in 2022, then retreated by 1.73% to $98.8 billion in 2023, then gained by 9.95% to $108.6 billion in 2024, then gained by 8.33% to $117.7 billion in 2025, then climbed by 1.74% to $119.7 billion in 2026.
  • Business Quant data shows JNJ's Total Liabilities at $119.7 billion in Q1 2026, $117.7 billion in Q4 2025, and $113.5 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 85.38 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 119.71 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 143.12 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -66.63 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 82.81 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 83.31 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 32.76 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 117.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn 10.83 Bn

Historic Data

Download Data
DateValue
Mar 29, 2026 119.71 Bn
Dec 28, 2025 117.67 Bn
Sep 28, 2025 113.54 Bn
Jun 29, 2025 114.92 Bn
Mar 30, 2025 115.56 Bn
Dec 29, 2024 108.61 Bn
Sep 29, 2024 108.13 Bn
Jun 30, 2024 109.55 Bn
Mar 31, 2024 101.95 Bn
Dec 31, 2023 98.78 Bn
Oct 1, 2023 94.83 Bn
Jul 2, 2023 115.28 Bn
Apr 2, 2023 125.10 Bn
Jan 1, 2023 110.57 Bn
Oct 2, 2022 100.53 Bn
Jul 3, 2022 101.37 Bn
Apr 3, 2022 103.65 Bn
Jan 2, 2022 108.00 Bn
Oct 3, 2021 108.96 Bn
Jul 4, 2021 106.86 Bn